Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolism
Linjie Zhao,Zhixin Qiu,Zhengnan Yang,Lian Xu,Thomas M Pearce,Qiulian Wu,Kailin Yang,FuLong Li,Olivier Saulnier,Fan Fei,Huaxu Yu,Ryan C Gimple,Venkateshwari Varadharajan,Juxiu Liu,Liam D Hendrikse,Vernon Fong,Wei Wang,Jiao Zhang,Deguan Lv,Derrick Lee,Brandon M Lehrich,Chunyu Jin,Liang Ouyang,Deobrat Dixit,Haoxing Wu,Xiang Wang,Andrew E Sloan,Xiuxing Wang,Tao Huan,J Mark Brown,Steven A Goldman,Michael D Taylor,Shengtao Zhou,Jeremy N Rich
DOI: https://doi.org/10.1038/s43018-023-00658-0
Abstract:Glioblastoma is the most lethal primary brain tumor with glioblastoma stem cells (GSCs) atop a cellular hierarchy. GSCs often reside in a perivascular niche, where they receive maintenance cues from endothelial cells, but the role of heterogeneous endothelial cell populations remains unresolved. Here, we show that lymphatic endothelial-like cells (LECs), while previously unrecognized in brain parenchyma, are present in glioblastomas and promote growth of CCR7-positive GSCs through CCL21 secretion. Disruption of CCL21-CCR7 paracrine communication between LECs and GSCs inhibited GSC proliferation and growth. LEC-derived CCL21 induced KAT5-mediated acetylation of HMGCS1 on K273 in GSCs to enhance HMGCS1 protein stability. HMGCS1 promoted cholesterol synthesis in GSCs, favorable for tumor growth. Expression of the CCL21-CCR7 axis correlated with KAT5 expression and HMGCS1K273 acetylation in glioblastoma specimens, informing patient outcome. Collectively, glioblastomas contain previously unrecognized LECs that promote the molecular crosstalk between endothelial and tumor cells, offering potentially alternative therapeutic strategies.